Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

被引:484
作者
Vergote, I [1 ]
De Brabanter, J
Fyles, A
Bertelsen, K
Einhorn, N
Sevelda, P
Gore, ME
Kærn, J
Verrelst, H
Sjövall, K
Timmerman, D
Vandewalle, J
Van Gramberen, M
Tropé, CG
机构
[1] Univ Hosp Leuven, Dept Gynaecol Oncol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Dept Elect Engn, Louvain, Belgium
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Odense Univ Hosp, DK-5000 Odense, Denmark
[5] Karolinska Hosp, S-10401 Stockholm, Sweden
[6] Univ Hosp, Vienna, Austria
[7] Royal Marsden NHS Trust, London, England
[8] Norwegian Radium Hosp, Oslo, Norway
关键词
D O I
10.1016/S0140-6736(00)03590-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies on prognostic factors in stage I invasive epithelial ovarian carcinoma have been too small for robust conclusions to be reached. We undertook a retrospective study in a large international database to identify the most important prognostic variables. Methods 1545 patients with invasive epithelial ovarian cancer (International Federation of Gynaecology and Obstetrics [FIGO] stage I) were included. The records of these patients were examined and data extracted for univariate and multivariate analysis of disease-free survival in relation to various clinical and pathological variables. Findings The multivariate analyses identified degree of differentiation as the most powerful prognostic indicator of disease-free survival (moderately vs well differentiated hazard ratio 3.13 [95% CI 1.68-5.85], poorly vs well differentiated 8.89 [4.96-15.9]), followed by rupture before surgery (2.65 [1.53-4.56]), rupture during surgery (1.64 [1.07-2.51]), FIGO 1973 stage Ib vs Ia 1.70 [1.01-2.85]) and age (per year 1.02 [1.00-1.03]). When the effects of these factors were accounted for. none of the following were of prognostic value: histological type, dense adhesions, extracapsular growth, ascites, FIGO stage 1988, and size of tumour. Interpretation Degree of differentiation, the most powerful prognostic indicator in stage I ovarian cancer, should be used in decisions on therapy in clinical practice and in the FIGO classification of stage I ovarian cancer. Rupture should be avoided during primary surgery of malignant ovarian tumours confined to the ovaries.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 32 条
[1]   Natural history and prognosis of untreated stage I epithelial ovarian carcinoma [J].
Ahmed, FY ;
Wiltshaw, E ;
AHern, RP ;
Nicol, B ;
Shepherd, J ;
Blake, P ;
Fisher, C ;
Gore, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :2968-2975
[2]  
BAAK JPA, 1986, ANAL QUANT CYTOL, V8, P354
[3]   COMPARISON OF STOPPING RULES IN FORWARD STEPWISE REGRESSION [J].
BENDEL, RB ;
AFIFI, AA .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1977, 72 (357) :46-53
[4]   OVARIAN-CANCER SPREAD - IS LAPAROSCOPY TO BLAME [J].
BEREK, JS .
LANCET, 1995, 346 (8969) :200-200
[5]   PROGNOSTIC FACTORS AND ADJUVANT TREATMENT IN EARLY EPITHELIAL OVARIAN-CANCER [J].
BERTELSEN, K ;
HOLUND, B ;
ANDERSEN, JE ;
NIELSEN, K ;
STROYER, I ;
LADEHOFF, P .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (04) :211-218
[6]   Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (P-32) [J].
Bolis, G ;
Colombo, N ;
Pecorelli, S ;
Torri, V ;
Marsoni, S ;
Bonazzi, C ;
Chiari, S ;
Favalli, G ;
Mangili, C ;
Presti, M ;
Zanaboni, F ;
Mangioni, C .
ANNALS OF ONCOLOGY, 1995, 6 (09) :887-893
[7]   COVARIANCE ANALYSIS OF CENSORED SURVIVAL DATA [J].
BRESLOW, N .
BIOMETRICS, 1974, 30 (01) :89-99
[8]  
Cox D. R., 1984, ANAL SURVIVAL DATA
[9]  
DELACUESTA RS, 1994, OBSTET GYNECOL, V84, P1
[10]  
DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263